Franklyn Prendergast

Franklyn Prendergast

Director/Board Member bei NEUBASE THERAPEUTICS, INC.

Vermögen: 2 Mio $ am 31.03.2024

79 Jahre
Health Technology
Commercial Services
Consumer Services

Profil

Franklyn G.
Prendergast
is currently serving as the Chairman at Infectious Disease Research Institute.
He is also the Director at Predictive Health Technologies, Inc., Mill Creek Life Sciences LLC, Ativa Medical Corp., On Target Laboratories LLC, Perimeter Medical Imaging, Inc., NeuBase Therapeutics, Inc., Novosteo, Inc., MorphImmune, Inc., and iGan Partners.
Additionally, he is a Member of the American Chemical Society, American Cancer Society, Inc., Sigma XI, American Society for Biochemistry & Molecular Biology, Inc., and The Biophysical Society.
He holds the position of Clinical & Technical Advisor at iGan Partners and is a Professor-Emeritus at Mayo Medical School.
Previously, Dr. Prendergast served as an Independent Director at Eli Lilly & Co. from 1995 to 2017.
He was also a Director at GMP Cos., Inc., Acelerate, Inc., DemeRx, Inc., TrivarX Ltd., Cancer Genetics, Inc., Translational Genomics Research Institute, Liquid Bioscience, Inc., Mayo Clinic Cancer Center, Neubase Therapeutics, Inc., Perimeter Medical Imaging AI, Inc., and Vyant Bio, Inc. He held the position of Non-Executive Director at TrivarX Ltd.
from 2016 to 2019.
He was a Director at Lantern Pharma, Inc. and Immunome, Inc. He served as a Trustee at The Mayo Clinic (Old) from 1992 to 2014 and was a Member-Governors Board at Mayo Clinic from 1989 to 1996.
He also held positions at Mayo Foundation for Medical Education & Research, National Cancer Institute, National Academy of Sciences, American Association for the Advancement of Science, National Institute of Health Policy, Molecular Biology Resources, Inc., and Mayo Clinic College of Medicine & Science.
Dr. Prendergast completed his graduate degree from the University of Oxford in 1979.
He obtained his doctorate degree from the University of Minnesota in 1977 and also holds a doctorate degree from The University of the West Indies, conferred in 1968.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
02.10.2023 60 840 ( 0,11% ) 2 Mio $ 31.03.2024
04.08.2023 0 ( -.--% ) - $ 31.03.2024
15.04.2023 0 ( -.--% ) - $ 31.03.2024

Aktive Positionen von Franklyn Prendergast

UnternehmenPositionBeginn
NEUBASE THERAPEUTICS, INC. Director/Board Member 12.07.2019
Director/Board Member -
Mayo Medical School Corporate Officer/Principal -
Consultant / Advisor -
Director/Board Member -
Chairman -
Director/Board Member -
Director/Board Member -
Corporate Officer/Principal 22.03.2010
░░░ ░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Alle aktiven Positionen von Franklyn Prendergast

Ehemalige bekannte Positionen von Franklyn Prendergast

UnternehmenPositionEnde
░░░░░ ░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░ ░░░░░ ░░░ ░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░ ░░░░ ░░░░░░ ░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Franklyn Prendergast im Detail an

Ausbildung von Franklyn Prendergast

University of Oxford Graduate Degree
University of Minnesota Doctorate Degree
The University of the West Indies Doctorate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Franklyn Prendergast im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

43

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen7
ELI LILLY AND COMPANY

Health Technology

IMMUNOME, INC.

Health Technology

TRIVARX LIMITED

Technology Services

LANTERN PHARMA INC.

Health Technology

NEUBASE THERAPEUTICS, INC.

Health Technology

PERIMETER MEDICAL IMAGING AI, INC.

Health Technology

VYANT BIO, INC.

Health Technology

Private Unternehmen31

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Commercial Services

Health Technology

Health Services

Health Services

Commercial Services

Miscellaneous

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Commercial Services

National Institute of Health Policy

Commercial Services

Process Industries

Health Technology

Health Technology

Health Technology

Commercial Services

Health Services

Health Technology

Health Technology

Health Technology

Center For Individualized Medicine

Finance

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Franklyn Prendergast